M. Hashmonai, 2005
President of the International Society of Sympathetic Surgery
"Sympathectomy is a technique about which we have limited knowledge, applied to disorders about which we have little understanding." Associate Professor Robert Boas, Faculty of Pain Medicine of the Australasian College of Anaesthetists and the Royal College of Anaesthetists, The Journal of Pain, Vol 1, No 4 (Winter), 2000: pp 258-260
the symptoms of Autonomic Neuropathy closely resemble the symptoms described by many who have undergone sympathectomy - a surgery where the surgeon destroys part of the ANS, a surgery that can result in a deranged functioning of the ANS. Surgeons are allowed to market ETS/ESB as an elective (life-style) procedure, often referred to as a 'cure'. Autonomic neuropathy: | |
"Cardiovascular symptoms: exercise intolerance, fatigue, sustained heart rate, syncope, dizziness, lightheadedness, balance problems | |
Gastrointestinal symptoms: dysphagia, bloating, nausea and vomiting, diarrhea, constipation, loss of bowel control | |
Genitourinary symptoms: loss of bladder control, urinary tract infection, urinary frequency or dribbling, erectile dysfunction, loss of libido, dyspareunia, vaginal dryness, anorgasmia | |
Sudomotor (sweat glands) symptoms: pruritus, dry skin, limb hair loss, calluses, reddened areas | |
Endocrine symptoms: hypoglycemic unawareness | |
Other symptoms: difficulty driving at night, depression, anxiety, sleep disorders, cognitive changes" |
After stellate ganglion blockade: HORNER'S SYNDROME
After regional sympathectomy: DUMPING SYNDROME:
Peripheral
Amyloidosis
Diabetic, alcoholic, or nutritional neuropathy
Familial dysautonomia (Riley-Day syndrome)
Guillain-Barré syndrome
Paraneoplastic syndromes
Pure autonomic failure (formerly called idiopathic orthostatic hypotension)
Surgical sympathectomy
http://www.merckmanuals.com/professional/sec07/ch069/ch069d.htmlEndoscopic thoracic sympathectomy (ETS) for palmar hyperhidrosis was performed using a 3-mm small endoscope at our hospital, and we conducted a questionnaire for the purpose of studying the conditions and satisfaction after surgery. The subjects were comprised of 50 patients, of which 35 patients (75%) answered the survey. The average age of the respondents was 27 years old (range: 12?62 years old) including 13 males and 22 females and the average postoperative observation period was 33 months (1?114 months). The results showed the good effects of surgery in all of the patients for palmar sweating while patient satisfaction was 79.4 points, which concluded that ETS was sufficiently accepted as treatment for palmar hyperhidrosis. However, compensatory sweating (CS) developed in 97.1% of the patients, and 82.9% answered that they were disturbed because it was more than they had expected. This result makes us realize further the importance of preoperative informed consent for CS. The problem of palmar hyperhidrosis is very serious for patients, and hence it is important to give treatment with a thorough understanding of the effectiveness and problems of ETS for palmar hyperhidrosis according to the analytical results of this questionnaire.
"Recurrent and enhanced vasoconstrictor function 3 months following endoscopic sympathetic block has major implications for its use to treat enhanced vasoconstriction."
HR and BP at rest and cardiovascular response to exercise were similar in patients with palmar hyperhidrosis before ETS and in the normal control population. Therefore, we consider that patients with palmar hyperhidrosis have no overactivity of the sympathetic nerve. However, because bilateral ETS causes the suppression of cardiovascular response to exercise, patients that has been treated with ETS need to be observed during high-level exercise.
http://iars.org/abstracts/browsefile/browse.asp?command=N&absnum=45&dir=S190
After a mean of 123 mo 36 patients could be re-evaluated. Eighteen patients (50%) were free from former symptoms, while sequels were still present in 18 patients (50%).
Numbness and paresthesia are rarely reported in the literature but are present in up to 10% of patients 1 year after a thoracoscopic procedure [2,9]. It is known that numbness and dysesthesia may decrease by time, but long-term results are not known.
Many studies have demonstrated that ablation of the sympathetic nervous system (SNS) alters subsequent immune responses. Researchers have presumed that the altered immune responses are predominantly the result of the peripheral phenomenon of denervation. We, however, hypothesized that chemical sympathectomy will signal and activate the central nervous system (CNS).
Dual-antigen labeling demonstrates that
corticotrophin releasing factor (CRF)-containing neurons in the PVN are
activated by chemical sympathectomy; however, neurons containing
neurotransmitters which may modulate CRF neurons, such as vasopressin,
tyrosine hydroxylase, and adrenocorticotropin, do not coexpress Fos. Our
findings suggest an involvement of the CNS insympathectomy-induced
alterations of immunity.
Brain, Behavior, and Immunity
Volume 12, Issue 3, September 1998, Pages 230-241
Bilateral cervical sympathectomy reduced mechanical allodynia and cold allodynia in the rat
model of neuropathic pain suggesting that neuropathic pain, although the lesions are localized in low extremities, may be correlated with functional disturbance of sympathetic nerve fibers of supraspinal or brain level and help explain the mechanism of neuropathic pain.
Korean J Anesthesiol. 1999 Feb;36(2):327-334. Korean.
http://www.springerlink.c...ontent/j705306763158841/
Some workers suggest a possible "transmembrane" role of PG in the nervous system.
If the increase in the PG level during ischemia is regarded as a protective reaction, it must be admitted that no increase took place 1 day after CSE (cervical sympathectomy) and it was considerably weakened 7-40 days after CSE.
The effect of cerebral ischemia was virtually indistinguishable from the action of CSE itself.
It can be tentatively suggested that PGF plays the main role in the regulation of tone of the vascular wall and in the regulation of metabolism under conditions of ischemia when the sympathetic regulation is disturbed.
Objective: Analyzing changes in regional cerebral blood flow (rCBF) with SPECT in complex regional pain syndrome type 1 (CRPS 1), formerly known as reflex sympathetic dystrophy, is an optimal method for evaluating effective pain relief. We attempted to investigate the correlation of changes in rCBF with pain relief during treatments of sympathetic blockade and multimodal epidural pain control.
Case Report: We describe a patient with severe CRPS 1 in whom conventional treatment failed to relieve the pain.
Combined repeated lumbar sympathetic blocks and long-term epidural morphine, bupivacaine, and ketamine administration provided satisfactory pain relief and functional activity recovery. Six normal control subjects having one Tc-99m HMPAO scan each and the patient with CRPS having 3 Tc-99m HMPAO scans (once before treatment and twice at 4 months and 6 months after treatment, respectively). The patient with CRPS showed lower rCBF than normal
controls in the left thalamus and higher rCBF than normal controls in the right parietal lobe and left frontal lobe.
After subsequent treatment, the subtraction images showed increased rCBF in the left thalamus and decreased rCBF in the right parietal and left frontal lobes.
Conclusions: Tc-99m HMPAO SPECT showed a relationship of rCBF in the thalamus, parietal lobe, and frontal lobe with pain relief. rCBF alterations may provide an indicator for the quality of pain management for neuropathic pains.
Subtraction analysis between pre- and posttreatment, by using statistical parametric mapping (version 2), can be used as an objective indicator for the effectiveness of therapy.
Dermatology Unit, North Devon Healthcare Trust, Barnstaple, UK. karen.davies@ndevon.swest.nhs.uk
http://www.ncbi.nlm.nih.gov/pubmed/20028410
To retrospectively review the results of cervical perivascular sympathectomy (CPVS) in treating athetoid cerebral palsy and discuss the possible mechanism of the surgery.
METHODS: From 1998 to 2006,560 patients with athetoid cerebral palsy were treated with cervical perivascular sympathectomy and all had periodical follow-up at 1 week, 6 months and 1 year postoperatively. Among the 560 patients,there were 391 boys and 169 girls. The age at operation was from 3 to 25 years old with an average of 10.7 years.
RESULTS: At 1 year follow-up postoperatively, among the 560 cases, athetoid movement of the neck and head improved in 308 patients (55%), the movement of the hand and fingers improved in 403 patients (72%), standing and gait improved in 229 patients (41%), muscle tone reduced in 185 patients (33%), salvation reduction appeared in 252 patients (45%), eyeball movement improved in 174 patients (31%), speaking improved in 251 patients (45%); 310 patients (55%) agreed that the operation had curative effect for the patients. Short-term follow up results was better than long-term follow up results.
CONCLUSION: Primary results showed that CPVS had a curative effect on athetoid cerebral palsy, especially in improving athetoid movement of the neck and head, hand and fingers, standing and gait, speaking ability, eye-ball movement and so on. The possible mechanism of the CPVS in the treatment of athetoid cerebral palsy might be reducing the excitability of sympathetic nerve, improving microcirculation of the brain and eventually activating potential neurons. Long-term follow up is necessary.
http://www.ncbi.nlm.nih.gov/pubmed/20486384
Long-term superior cervical sympathectomy induces mast cell hyperplasia and increases histamine and serotonin content in the rat dura mater.
Neuroscience. 2000;96(1):205-13.
Mast cell hyperplasia is found in different pathologies such as chronic inflammatory
processes, fibrotic disorders, wound healing or neoplastic tissue transformation. The
functional significance of the accumulation of mast cells in these processes is largely
unknown. It is now established that bone marrow-derived mast cell progenitors
circulate in peripheral blood and subsequently migrate into the tissue where they
undergo final maturation under the influence of local microenvironmental factors.
Cytokines are of particular importance for mast cell recruitment, development, and
function. Stem cell factor (SCF) is a unique mast cell growth factor, since mast cells
disappear completely in the absence of SCF. However, several other cytokines such
as IL-3 and IL-4 have been shown to influence mast cell proliferation and function
also. This review focuses on the role of cytokines in the regulation of mast cell
hyperplasia.
This study was performed to determine to what extent the morphology of the rabbit middle cerebral artery is affected by the absence of the sympathetic nervous system. Six weeks after unilateral ablation of the superior cervical ganglion, which induced ipsilateral degeneration and disappearance of the perivascular noradrenergic nerve fibers, comparison between the ipsi- and the contralateral middle cerebral arteries revealed that the denervated arterial wall underwent significant thickening. This thickening was principally due to hypertrophy of the smooth muscle cells (SMC), together with an increase in the amount of medial and adventitial collagen. The hypertrophied SMC showed important morphological and ultrastructural modifications – irregular shape, increase in the number of organdies (particularly of Golgi apparatus, free ribosomes, rough endoplasmic reticulum and microtubules), large indented nuclei rich in euchromatin – indicating profound changes in their metabolic and contractile activity which could result in an alteration of their mechanical properties. As these alterations were strictly ipsilateral to the sympathectomy it is likely that they are the direct consequence of the suppression of a regulatory ‘trophic’ factor linked to the presence of sympathetic nerve fibers. This concept is reinforced by the fact that the first SMC affected are those situated at the media/adventitial border, in the vicinity of adventitial nerve bundles. Thus, the sympathetic nervous system appears to play a key role in the long-term regulation of the cerebral vascular tree structure.
Copyright © 1988 S. Karger AG, Basel
It is thought that this novel purinergic sensitivity may contribute to neuropathic paraesthesia and pain.
CHEN YONG, ZHANG YI-HONG, BIE BI-HUA, ZHAO ZHI-QI
Shanghai Institute of Physiology, Chinese Academy of Sciences
Acta Pharmacol Sin, 2000 Nov; 21 (11):1002-1004
Many studies have demonstrated that ablation of the sympathetic nervous
system (SNS) alters subsequent immune responses. Researchers have
presumed that the altered immune responses are predominantly the result
of the peripheral phenomenon of denervation. We, however, hypothesized
that chemical sympathectomy will signal and activate the central nervous
system (CNS). Activation of the CNS was determined by
immunocytochemical visualization of Fos protein in brains from male
C57BL/6 mice at 8, 24, and 48 h following denervation. A dramatic
induction of Fos protein was found in the paraventricular nucleus (PVN) of
the hypothalamus and other specific brain regions at 8 and 24 h compared
to vehicle control mice. Dual-antigen labeling demonstrates that
corticotrophin releasing factor (CRF)-containing neurons in the PVN are
activated by chemical sympathectomy; however, neurons containing
neurotransmitters which may modulate CRF neurons, such as vasopressin,
tyrosine hydroxylase, and adrenocorticotropin, do not coexpress Fos. Our
findings suggest an involvement of the CNS in sympathectomy-induced
alterations of immunity.
Central Nervous System Activation following Peripheral Chemical Sympathectomy: Implications for Neural–Immune Interactions
Brain, Behavior, and Immunity
Volume 12, Issue 3, September 1998, Pages 230-241